Tag archive for ‘Valeant Pharmaceuticals’
Niva Goldberg On Tuesday, March 14th, 2017

Bill Ackman sells disastrous stake in Valeant at huge loss

In dramatic step, finally, billionaire hedge fund Bill Ackman on Monday threw in the towel on Valeant pharmaceuticals, investment he made three years ago. In all, the loss totals nearly $4 billion, Forbes reported. Not More...

News Brief On Tuesday, April 26th, 2016

Senate Hearing Into Valeant Includes Top Hedge Fund Investor

Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company’s leading investors, hedge fund manager William Ackman. The Senate Aging More...

Jewish Business News On Sunday, December 27th, 2015

CEO of troubled pharmaceutical company Valeant admitted to hospital with ‘severe’ pneumonia

  CEO Michael Pearson has been admitted for “severe” pneumonia, an emailed statement from Valeant spokeswoman Laurie Little says. J. Michael Pearson, 56, was admitted recently and is receiving More...

News On Thursday, November 12th, 2015

Bill Ackman Defends Pershing Square’s Losses in Valeant Investment

  From 2010, Valeant shares rose more than 10-fold to peak in August. Unfortunately, from a systemic perspective, just about every American is worse off as a result of Valeant’s strategy. Still, Valeant More...

News Brief On Friday, October 30th, 2015

Herbalife just fired a massive shot at Bill Ackman in an epic one sentence press release

Bill Ackman is about to hold a call defending his position in Valeant Pharmaceuticals. And ahead of this call, Herbalife, the nutritional supplement company Ackman is famously betting against and has called More...

News Brief On Saturday, October 3rd, 2015

Bill Ackman’s hedge fund had a brutal month

Bill Ackman’s Pershing Square Capital, got pounded in September. The hedge fund was the best-performing last year, returning 40.4%. Last month the fund’s publicly traded vehicle, fell 12.5% for the More...

Vered Weiss On Monday, March 9th, 2015

What Plans Does Bill Ackman Have for Valeant with his $3.3 Billion Stake?

Pershing Square’s Bill Ackman didn’t manage to make Valeant into a successful hunter, so one wonders, with his $3.3 billion stake, as reported by Reuters, will he make Valeant, like he did Allergan, More...

Vered Weiss On Wednesday, February 18th, 2015

Carl Icahn Wants Apple to Show him the Money

Some activist investors want power, others prefer the cash. Since Bill Ackman’s  very activist-oriented Pershing Square was a top performer in 2014, it seems that other big investors are realizing that More...

Vered Weiss On Thursday, February 12th, 2015

Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job

One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...

Reuters On Tuesday, December 9th, 2014

Exclusive: Valeant to drop deal-making in near term to cut debt, boost stock

– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making More...

Wordpress site Developed by Fixing WordPress Problems